XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/gt-biopharma-inc-gtbp-announces-50-enrollment-in-proof-of-concept-clinical-trial-for-its-novel-treatment/20%Monthly2018-06-06 16:35
https://biotechstocks.com/sorrento-therapeutics-inc-nasdaqsrne-appoints-jiong-shao-to-the-position-of-a-chief-financial-officer/20%Monthly2018-03-29 10:46
https://biotechstocks.com/glaxosmithkline-plc-adr-nysegsk-is-reallocating-its-budget-to-key-new-drugs/20%Monthly2018-03-29 10:45
https://biotechstocks.com/immunogen-inc-nasdaqimgn-undertakes-data-presentation-of-forward-ii-assessment-of-products/20%Monthly2018-03-29 11:22
https://biotechstocks.com/celgene-corporation-nasdaqcelg-hopes-to-reach-a-settlement-over-generic-revlimid/20%Monthly2018-03-28 14:27
https://biotechstocks.com/aytu-bioscience-inc-nasdaqaytu-unleashes-its-research-findings-in-line-with-natesto/20%Monthly2018-03-28 13:35
https://biotechstocks.com/opko-health-publicizes-the-results-of-a-20-year-long-4kscore-test-for-prostate-cancer/20%Monthly2018-03-28 06:28
https://biotechstocks.com/marinus-pharmaceuticals-inc-nasdaqmrns-reports-on-its-clinical-development-activities-and-2017-financial-results/20%Monthly2018-03-27 13:27
https://biotechstocks.com/prothena-corporation-plc-nasdaqprta-partners-with-celgene-corporation-nasdaqcelg-in-the-development-and-commercialization-of-novel-therapies/20%Monthly2018-03-27 11:12
https://biotechstocks.com/oasis-trial-from-arena-pharmaceuticals-inc-nasdaqarna-met-primary-and-all-secondary-endpoints/20%Monthly2018-03-27 07:01
https://biotechstocks.com/exelixis-inc-nasdaqexel-announces-completion-of-the-submission-of-a-new-drug-application-cabometyx/20%Monthly2018-03-27 11:18
https://biotechstocks.com/corcept-therapeutics-incorporated-nasdaqcort-litigates-teva-pharmaceutical-industries-ltd-adr-adr-nyseteva-for-infringement-of-korlym-patents/20%Monthly2018-03-26 06:41
https://biotechstocks.com/the-fda-confirms-the-completion-of-reasonable-expectation-of-effectiveness-rxe-technical-section-from-jaguar-health-inc-nasdaqjagx/20%Monthly2018-03-26 06:40
https://biotechstocks.com/gt-biopharma-inc-announces-additional-positive-data-from-its-phase-1-clinical-trial-for-myasthenia-gravis-and-potential-for-acceleration-of-the-start-of-its-phase-2-trial/20%Monthly2018-06-06 17:57
https://biotechstocks.com/biopharmx-corp-nyseamericanbpmx-is-awarded-patent-protection-for-its-novel-tetracycline-class-topical-drug-compositions/20%Monthly2018-03-23 15:22
https://biotechstocks.com/what-is-the-buzz-surrounding-endocyte-inc-nasdaqecyt/20%Monthly2018-03-23 11:58
https://biotechstocks.com/amicus-therapeutics-inc-nasdaqfold-introduces-healing-beyond-disease-measures/20%Monthly2018-03-23 11:57
https://biotechstocks.com/agenus-inc-nasdaqagen-posts-q4-2017-financial-report/20%Monthly2018-03-22 09:26
https://biotechstocks.com/editas-medicine-inc-nasdaqedit-outlines-recent-financial-performance/20%Monthly2018-03-22 09:27
https://biotechstocks.com/crispr-therapeutics-ag-nasdaqcrsp-total-collaboration-revenue-at-32-3-million-for-q4-2017/20%Monthly2018-03-22 09:28
https://biotechstocks.com/akcea-therapeutics-inc-nasdaqakca-announces-positive-phase-12-results-of-akcea-apociii-lrx/20%Monthly2018-03-21 09:12
https://biotechstocks.com/how-adverum-biotechnologies-inc-nasdaqadvm-fared-in-q4-2017/20%Monthly2018-03-21 11:47
https://biotechstocks.com/biopharmx-corp-nyseamericanbpmx-to-present-at-oppenheimers-annual-healthcare-conference/20%Monthly2018-03-21 11:46
https://biotechstocks.com/oncosec-medical-incorporated-oncs-announces-strategic-relocation-of-office-and-laboratories/20%Monthly2018-03-20 13:42
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-reports-positive-results-on-its-rare-blood-disorder/20%Monthly2018-03-20 08:52
https://biotechstocks.com/anthera-pharmaceuticals-incs-nasdaqanth-sollpura-did-not-achieve-the-primary-endpoint-of-the-result-phase-3-clinical-study/20%Monthly2018-03-20 08:51
https://biotechstocks.com/adaptimmune-therapeutics-plc-adr-nasdaqadap-reports-of-evidence-of-the-potential-of-the-ny-eso-spear-t-cells/20%Monthly2018-03-20 08:50
https://biotechstocks.com/insys-therapeutics-inc-insy-therapeutics-reiterates-commitment-to-compliant-and-ethical-business-practices/20%Monthly2018-03-19 13:25
https://biotechstocks.com/regeneron-pharmaceuticals-inc-regn-announced-that-the-phase-3-panorama-trial-evaluating-eylea/20%Monthly2018-03-19 13:19
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-canada-supports-community-leaders-with-local-hepatitis-c-micro-elimination-efforts/20%Monthly2018-03-19 07:25
https://biotechstocks.com/jaguar-health-inc-nasdaqjagx-provides-updates-on-its-commercial-educational-and-product-development/20%Monthly2018-03-19 07:22
https://biotechstocks.com/achillion-pharmaceuticals-inc-nasdaqachn-launches-a-wec3g-initiative-to-raise-awareness-for-c3g/20%Monthly2018-03-19 07:21
https://biotechstocks.com/oncosec-medical-incorporated-oncs-to-present-at-the-oppenheimers-28th-annual-healthcare-conference/20%Monthly2018-03-16 13:14
https://biotechstocks.com/abbvie-inc-nyseabbv-and-biogen-inc-nasdaqbiib-working-on-withdrawing-marketing-authorizations-for-zinbryta/20%Monthly2018-03-16 10:34
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-has-a-new-partnership-with-boston-childrens-hospital/20%Monthly2018-03-16 10:33
https://biotechstocks.com/sangamo-therapeutics-inc-nasdaqsgmo-takes-to-reporting-the-inducement-grant-under-nasdaq-listing-rule-5635c4/20%Monthly2018-03-16 10:31
https://biotechstocks.com/alexion-pharmaceuticals-inc-alxn-positive-top-line-results-showing-successful-phase-3-clinical-study-of-alxn1210/20%Monthly2018-03-15 12:32
https://biotechstocks.com/biogen-biib-to-present-at-the-2018-advances-in-alzheimers-and-parkinsons-therapies-aat-adpd-focus-meeting-2/20%Monthly2018-03-15 12:31
https://biotechstocks.com/oncosec-medical-incorporated-oncs-intratumoral-il-12-in-metastatic-triple-negative-breast-cancer-tnbc-selected-for-oral-poster-presentation/20%Monthly2018-03-15 12:29
https://biotechstocks.com/progenics-pharmaceuticals-inc-nasdaqpgnx-unleashes-its-business-update-and-financial-results/20%Monthly2018-03-15 08:52
https://biotechstocks.com/biogen-biib-to-present-at-the-2018-advances-in-alzheimers-and-parkinsons-therapies-aat-adpd-focus-meeting/20%Monthly2018-03-15 12:27
https://biotechstocks.com/pdl-biopharma-inc-nasdaqpdli-unveils-results-for-the-fourth-quarter-and-full-year/20%Monthly2018-03-15 08:50
https://biotechstocks.com/array-biopharma-inc-nasdaqarry-unveils-the-second-quarter-financial-results/20%Monthly2018-03-15 08:48
https://biotechstocks.com/ibio-inc-ibio-selects-lead-candidate-for-its-fibrosis-therapeutics-program/20%Monthly2018-03-14 13:30
https://biotechstocks.com/atara-biotherapeutics-inc-nasdaqatra-pronounces-recent-operational-progress-and-its-financial-results/20%Monthly2018-03-14 12:06
https://biotechstocks.com/biomarin-pharmaceutical-inc-nasdaqbmrn-unveils-its-2017-financial-results/20%Monthly2018-03-14 12:05
https://biotechstocks.com/22nd-century-group-inc-nyseamericanxxii-to-soon-unleash-its-business-update/20%Monthly2018-03-14 12:03
https://biotechstocks.com/amicus-therapeutics-inc-nasdaqfold-unveils-the-corporate-updates-for-the-year-ended-2018/20%Monthly2018-03-13 13:05
https://biotechstocks.com/opko-health-inc-nasdaqopk-unveils-business-highlights-for-the-fourth-quarter/20%Monthly2018-03-13 13:02
https://biotechstocks.com/immunogen-inc-nasdaqimgn-reports-significant-operational-and-financial-progress-in-2017/20%Monthly2018-03-13 08:09
https://biotechstocks.com/gtbp-to-present-at-roth-capital-partners-30th-annual-conference/20%Monthly2018-06-06 16:37
https://biotechstocks.com/the-european-medicines-agency-issues-positive-opinion-for-orphan-drug-designation-to-c3g-from-achillion-pharmaceuticals-inc-nasdaqachn/20%Monthly2018-03-12 09:35
https://biotechstocks.com/biogen-inc-nasdaqbiib-and-abbvie-inc-nyseabbv-voluntarily-withdraws-multiple-sclerosis-therapy-zinbryta-from-the-market/20%Monthly2018-03-12 09:33
https://biotechstocks.com/tenax-therapeutics-inc-nasdaqtenx-publicizes-the-publication-of-a-positive-preclinical-study-of-levosimendan/20%Monthly2018-03-12 09:30
https://biotechstocks.com/amgn-announced-data-from-two-new-studies-exploring-barriers-to-access-for-pcsk9-inh/20%Monthly2018-03-09 16:45
https://biotechstocks.com/advaxis-inc-adxs-host-business-update-and-first-quarter-2018-financial-results-conference-call/20%Monthly2018-03-09 14:12
https://biotechstocks.com/incyte-corporation-nasdaqincy-joins-the-community-in-raising-awareness-about-rare-disease-day/20%Monthly2018-03-09 06:38
https://biotechstocks.com/auris-medical-holding-ag-nasdaqears-report-confirms-the-superiority-of-bioavailability-of-intranasal-betahistine-in-humans/20%Monthly2018-03-09 06:39
https://biotechstocks.com/mannkind-corporation-nasdaqmnkd-reports-q4-and-full-year-2017-financial-results/20%Monthly2018-03-08 07:06
https://biotechstocks.com/acadia-pharmaceuticals-inc-nasdaqacad-presents-its-financial-results-for-the-fourth-quarter-of-2017/20%Monthly2018-03-08 07:14
https://biotechstocks.com/portola-pharmaceuticals-inc-nasdaqptla-posts-financial-results-for-q4-and-2017/20%Monthly2018-03-08 12:00
https://biotechstocks.com/ibio-inc-ibio-expands-antibody-development-and-production-services-to-include-fc-fusion-therapeutics/20%Monthly2018-03-07 14:09
https://biotechstocks.com/bluebird-bio-inc-blue-to-present-at-investor-conferences-in-march/20%Monthly2018-03-07 14:05
https://biotechstocks.com/novavax-inc-nasdaqnvax-reports-remarkable-results-on-its-flu-vaccine/20%Monthly2018-03-07 08:36
https://biotechstocks.com/jaguar-health-inc-nasdaqjagx-reports-on-the-commercial-educational-and-product-development-programs/20%Monthly2018-03-07 08:35
https://biotechstocks.com/the-fda-snubs-an-application-from-celgene-corporation-nasdaqcelg-for-ozanimod/20%Monthly2018-03-06 16:08
https://biotechstocks.com/amgen-amgn-announces-preliminary-results-of-tender-offer/20%Monthly2018-03-06 14:39
https://biotechstocks.com/celgene-corporation-celg-completes-acquisition-of-juno-therapeutics-inc/20%Monthly2018-03-06 14:31
https://biotechstocks.com/endocyte-and-itm-will-work-together-in-the-supply-of-no-carrier-added-lutetium/20%Monthly2018-03-06 06:11
https://biotechstocks.com/exelixiss-collaborator-daiichi-sankyo-files-regulatory-application-for-esaxerenone/20%Monthly2018-03-06 06:09
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-scaling-the-fight-against-cancer/20%Monthly2018-03-05 15:04
https://biotechstocks.com/what-is-the-buzz-surrounding-ziopharm-oncology-inc-nasdaqziop/20%Monthly2018-03-02 12:17
https://biotechstocks.com/bioverativ-inc-nasdaqbivv-q4-2017-revenue-jumps-28-3-yoy/20%Monthly2018-03-02 12:16
https://biotechstocks.com/kempharm-inc-nasdaqkmph-reports-fda-approval-of-apadaz/20%Monthly2018-03-02 12:14
https://biotechstocks.com/amarin-corporation-plc-amrn-start-of-final-clinical-site-visits-in-the-reduce-it-cardiovascular-outcomes-study/20%Monthly2018-03-01 13:29
https://biotechstocks.com/array-biopharma-inc-nasdaqarry-trades-in-red-zone/20%Monthly2018-03-01 11:35
https://biotechstocks.com/immunogen-inc-nasdaqimgn-updates-on-pipeline-progress-2/20%Monthly2018-03-01 11:34
https://biotechstocks.com/what-is-the-buzz-surrounding-aimmune-therapeutics-inc-nasdaqaimt/20%Monthly2018-03-01 11:32